Cureteq Ag A Partex

Biotechnology Research · 11 Employees
Email Address: info@cureteq.com
  • Overview
  • Employees
Access 5 Verified Employees Profiles for Cureteq Ag A PartexUnlock Free Contacts Now
About
Cureteq is an asset management and biotechnology company - enabled by artificial intelligence (AI). The cureteq platform has three main components: First, leveraging AI and data insights to in license drug candidates from pharmaceutical companies and biotech to unlock hidden value, e.g. assets that have gone under-prioritized or with promising data but outside company strategy. Further utilize AI in devising accelerated, optimized and de-risked clinical development programs. Second, an ecosystem of connected, yet independent, subsidiaries with each their disease area focus and leading the drug development of acquired assets; this secures agile and nimble drug development while retaining economies of scale and broader access to competences and resources as known from larger organizations. Finally, and third, flexibility around financing and partnering for each asset and subsidiary - patterning can be tailored to match the specific needs of asset, partners and investors.
Year Founded
2021
Social Media
Linkedin
Industry
Biotechnology Research
HQ Location
Baarerstrasse 18 Zug, ZG 6300, CH
Keywords
biotechnologydrug developmentartificialintelligenceand oncology
Location
  • Baarerstrasse 18 Zug, ZG 6300, CH

Email Formats

Sign up for free credits and discover verified email addresses of Cureteq Ag A Partex
FormatExamples
first + last
andywarhol@cureteq.com
first_initial + last
awarhol@cureteq.com
first + last_initial
andyw@cureteq.com
first
andy@cureteq.com
last
warhol@cureteq.com
Get Verified Emails for 5 Cureteq Ag A Partex Employees

Frequently Asked Questions

Learn More about Cureteq Ag A Partex

Similar Companies

Biotechnology Research

Get key business info for Cureteq Ag A Partex and other 100M companies. Start your seach.

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.